Literature DB >> 19662459

Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-ray cross-complementing group 1 (XRCC1).

Giovanni Corso1, Daniele Marrelli, Corrado Pedrazzani, José Carlos Machado, Stefano Mancini, Raquel Seruca, Franco Roviello.   

Abstract

PURPOSE: X-ray repair cross complementing group 1 (XRCC1) is one of the major DNA repair proteins involved in the bas-excision repair pathway. Several single-nucleotide polymorphisms in the XRCC1 gene are identified and related with increased cancer risk development. In particular, the -77T>C polymorphism located on the promoter region relates with lung cancer risk development. The aim of this study is to analyze the -77T>C allelic frequencies in a population composed of 456 primary gastric cancer patients (GC) and 507 blood donor controls.
METHODS: GC patients were observed at the University of Siena, Italy; clinicopathological data and family history were available for the cancer group. The control group is composed of blood donors. Constitutional genomic DNA was PCR amplified, and XRCC1 -77T>C was detected using restriction enzyme BsrB I and analyzed in a 3% agarose gel.
RESULTS: The -77C>C homozygous genotype was significantly associated with increased risk of gastric cardia carcinoma (p = 0.023) with an odds ratio of 1.65 (95% confidence interval 1.14 to 2.4). In the family history stratification, we report a significant association (p = 0.043) between the -77T>C polymorphism and GC cases with familial lung cancer aggregation.
CONCLUSIONS: Our results suggest that the XRCC1 -77T>C polymorphism is a relevant host susceptibility factor for gastric cardia cancer development and specific subsets of familial clustering of GC.

Entities:  

Mesh:

Year:  2009        PMID: 19662459     DOI: 10.1007/s11605-009-0980-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  27 in total

1.  Estimates of cancer incidence and mortality in Europe in 1995.

Authors:  F Bray; R Sankila; J Ferlay; D M Parkin
Journal:  Eur J Cancer       Date:  2002-01       Impact factor: 9.162

2.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

3.  Red meat, family history, and increased risk of gastric cancer with microsatellite instability.

Authors:  D Palli; A Russo; L Ottini; G Masala; C Saieva; A Amorosi; A Cama; C D'Amico; M Falchetti; R Palmirotta; A Decarli; R Mariani Costantini; J F Fraumeni
Journal:  Cancer Res       Date:  2001-07-15       Impact factor: 12.701

4.  Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas.

Authors:  P A Laurén; T J Nevalainen
Journal:  Cancer       Date:  1993-05-15       Impact factor: 6.860

5.  Prognostic significance of X-ray cross-complementing group 1 T-77C polymorphism in resected non-small cell lung cancer.

Authors:  Wei-Chung Hsieh; Ya-Wen Cheng; Cuei-Jyuan Lin; Ming-Chih Chou; Chih-Yi Chen; Huei Lee
Journal:  Jpn J Clin Oncol       Date:  2008-12-03       Impact factor: 3.019

6.  Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer.

Authors:  Daniele Marrelli; Corrado Pedrazzani; Anna Berardi; Giovanni Corso; Alessandro Neri; Lorenzo Garosi; Carla Vindigni; Annalisa Santucci; Natale Figura; Franco Roviello
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

7.  Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells.

Authors:  Ana Manuel Dantas Machado; Ceu Figueiredo; Eliette Touati; Valdemar Máximo; Sonia Sousa; Valérie Michel; Fátima Carneiro; Finn Cilius Nielsen; Raquel Seruca; Lene Juel Rasmussen
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

8.  A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma.

Authors:  José Carlos Machado; Céu Figueiredo; Paulo Canedo; Paul Pharoah; Ralph Carvalho; Sérgio Nabais; Catarina Castro Alves; Maria Luisa Campos; Leen-Jan Van Doorn; Carlos Caldas; Raquel Seruca; Fátima Carneiro; Manuel Sobrinho-Simões
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

9.  Evidence of tumor microsatellite instability in gastric cancer with familial aggregation.

Authors:  Corrado Pedrazzani; Giovanni Corso; Sérgia Velho; Marina Leite; Valeria Pascale; Francesca Bettarini; Daniele Marrelli; Raquel Seruca; Franco Roviello
Journal:  Fam Cancer       Date:  2009-01-17       Impact factor: 2.375

10.  XRCC1 is required for DNA single-strand break repair in human cells.

Authors:  Reto Brem; Janet Hall
Journal:  Nucleic Acids Res       Date:  2005-05-02       Impact factor: 16.971

View more
  5 in total

1.  Familial gastric cancer: update for practice management.

Authors:  Giovanni Corso; Daniele Marrelli; Franco Roviello
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

2.  Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis.

Authors:  Bo Chen; Yong Zhou; Ping Yang; Xiao-Ting Wu
Journal:  Mol Biol Rep       Date:  2011-05-22       Impact factor: 2.316

Review 3.  Genetic aspects of gastric cancer instability.

Authors:  Petra Hudler
Journal:  ScientificWorldJournal       Date:  2012-04-19

4.  Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells.

Authors:  Rebeka Sultana; Tarek Abdel-Fatah; Christina Perry; Paul Moseley; Nada Albarakti; Vivek Mohan; Claire Seedhouse; Stephen Chan; Srinivasan Madhusudan
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

5.  Association study of single nucleotide polymorphisms in XRCC1 gene with the risk of gastric cancer in Chinese population.

Authors:  Wen Qiao; Tao Wang; Li Zhang; Qing Tang; Dan Wang; Hongkun Sun
Journal:  Int J Biol Sci       Date:  2013-08-09       Impact factor: 6.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.